Table: AFC-HD Ams Life Science -2020/21 group results
Oct 15 (Reuters)-
AFC-HD Ams Life Science Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Aug 31, 2021 Aug 31, 2020 Aug 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 22.37 15.82
(+41.4 pct) (-2.7 pct)
Operating 2.25 1.09
(+105.3 pct) (+11.5 pct)
Recurring 2.16 1.10
(+96.6 pct) (+8.4 pct)
Net
Net 1.50 676 mln
(+121.0 pct) (-13.6 pct)
EPS 107.12 yen 48.12 yen
EPS Diluted 106.30 yen
Ann Div 27.50 yen 20.00 yen 30.00 yen
-Q2 Div 12.50 yen 10.00 yen 15.00 yen
-Q4 Div 15.00 yen 10.00 yen 15.00 yen
NOTE - AFC-HD Ams Life Science Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T